A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation

被引:61
|
作者
Keller, Dagmar I.
Huang, Hai
Zhao, Juan
Frank, Rudolf
Suarez, Vivian
Delacretaz, Etienne
Brink, Marijke
Osswald, Stefan
Schwick, Nicola
Chahine, Mohamed
机构
[1] Hop Laval, Quebec Heart Inst, Res Ctr, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Basel Hosp, Cardiobiol Res Grp, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland
[4] Tiefenau Hosp, Dept Cardiol, Bern, Switzerland
[5] Swiss Cardiovasc Ctr, Bern, Switzerland
基金
加拿大健康研究院;
关键词
Brugada syndrome; sudden cardiac death; genetics; SCN5A; sodium channel; Na(v)1.5; fever; ventricular fibrillation;
D O I
10.1016/j.cardiores.2006.02.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Brugada syndrome (BS) is an inherited electrical cardiac disorder characterized by right bundle branch block pattern and ST segment elevation in leads V1 to V3 on surface electrocardiogram that can potentially lead to malignant ventricular tachycardia and sudden cardiac death. About 20% of patients have mutations in the only so far identified gene, SCN5A, which encodes the alpha-subunit of the human cardiac voltage-dependent sodium channel (hNa(v)1.5). Fever has been shown to unmask or trigger the BS phenotype, but the associated molecular and the biophysical mechanisms are still poorly understood. We report on the identification and biophysical characterization of a novel heterozygous missense mutation in SCN5A, F1344S, in a 42-year-old male patient showing the BS phenotype leading to ventricular fibrillation during fever. Methods: The mutation was reproduced in vitro using site-directed mutagenesis and characterized using the patch clamp technique in the whole-cell configuration. Results: The biophysical characterization of the channels carrying the F1344S mutation revealed a 10mV mid-point shift of the G/V curve toward more positive voltages during activation. Raising the temperature to 40.5 degrees C further shifted the mid-point activation by 18mV and significantly changed the slope factor in Na(v)1.5/F1344S mutant channels from -6.49 to -10.27 mV. Conclusions: Our findings indicate for the first time that the shift in activation and change in the slope factor at a higher temperature mimicking fever could reduce sodium currents' amplitude and trigger the manifestation of the BS phenotype. (c) 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:521 / 529
页数:9
相关论文
共 45 条
  • [41] Patient with obstructive sleep apnea-hypopnea syndrome and SCN5A mutation (R1193Q polymorphism) associated with Brugada type 2 electrocardiographic pattern
    Qiu, Xiaoliang
    Liu, Wenling
    Hu, Dayi
    Sun, Yihong
    Li, Lei
    Li, Cuilan
    JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (03) : 250 - 253
  • [42] Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease
    Liu, Jie
    Bayer, Jason D.
    Aschar-Sobbi, Roozbeh
    Wauchop, Marianne
    Spears, Danna
    Gollob, Michael
    Vigmond, Edward J.
    Tsushima, Robert
    Backx, Peter H.
    Chauhan, Vijay S.
    PLOS ONE, 2018, 13 (05):
  • [43] Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome
    Nakajima, Tadashi
    Kaneko, Yoshiaki
    Saito, Akihiro
    Ota, Masaki
    Iijima, Takafumi
    Kurabayashi, Masahiko
    HEART RHYTHM, 2015, 12 (11) : 2296 - 2303
  • [44] Requirement of β subunit for the reduced voltage-gated Na+ current of a Brugada syndrome patient having novel double missense mutation (p.A385T/R504T) of SCN5A
    Park, Na Kyeong
    Choi, Seong Woo
    Park, Soon-Jung
    Woo, Joohan
    Kim, Hyun Jong
    Kim, Woo Kyung
    Moon, Sung-Hwan
    Park, Hun-Jun
    Kim, Sung Joon
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2024, 28 (04): : 313 - 322
  • [45] Generation of Induced Pluripotent Stem Cell Line FAMRCi012-A from a Patient with Ventricular Fibrillation Carrying Genetic Variant SCN5A p.Ser805Leu
    Nikitina, E. G.
    Garnyuk, V. V.
    Khudiakov, A. A.
    Perepelina, K. I.
    Rodina, N. L.
    Fomicheva, Yu. V.
    Zlotina, A. M.
    Mkrtchian, L. A.
    Mikhaylov, E. N.
    Lebedev, D. S.
    Kostareva, A. A.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2024, 55 (06) : 340 - 346